VERACYTE INC (VCYT:NASDAQ)
$51.22 0.3 (0.5892%)
Analysed VERACYTE INC (VCYT:NASDAQ) News Sources
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
25-05-2026
yahoo.com
Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?
27-05-2026
yahoo.com
Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy
29-05-2026
yahoo.com
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
30-05-2026
yahoo.com
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
01-06-2026
yahoo.com
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
04-06-2026
yahoo.com
How Veracyte (VCYT) Investors Can Read The Latest Unchanged Analyst Call
04-06-2026
yahoo.com
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
10-06-2026
yahoo.com
This Top Biotech Has Surged. CEO Explains Key To Veracyte's Success.
16-06-2026
yahoo.com
Dow Jones Futures: Techs Rebound, SpaceX Rises Despite Trump's Iran Threat; Warsh's Fed Debut Due
17-06-2026
yahoo.com
What is the current price of VERACYTE INC (VCYT:NASDAQ)?
The current price of VERACYTE INC (VCYT:NASDAQ) is $51.22.
VERACYTE INC (VCYT:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERACYTE INC (VCYT:NASDAQ) since the previous trading day is $0.3.
VERACYTE INC (VCYT:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERACYTE INC (VCYT:NASDAQ) since the previous trading day is 0.5892%.
What is the most recent average sentiment score for VERACYTE INC (VCYT:NASDAQ)?
The most recent average sentiment score for VERACYTE INC (VCYT:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for VERACYTE INC (VCYT:NASDAQ)?
The most recent sentiment for VERACYTE INC (VCYT:NASDAQ) is .
SEC-8K** Filing Available For VERACYTE INC (VCYT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.